Indeed, the IGFIR had been also shown to upregulate EphB4 in prostate cancer [5] but under the conditions used, such effect could be linked to both transcriptional and post-transcriptional mechanisms such as the presence of Ins receptor/IGFIR hybrids [46]. This evidence concerns the gene IGF1R and prostate carcinoma.